Symposia: Outcomes Research: Plasma Cell Disorders
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Research, Clinical Practice (Health Services and Quality), Elderly, Bispecific Antibody Therapy, Plasma Cell Disorders, Clinical Research, Health outcomes research, Supportive Care, Education, Health disparities research, Diseases, Therapy sequence, Immune Disorders, Immunodeficiency, Patient-reported outcomes, Treatment Considerations, Real-world evidence, Biological therapies, Lymphoid Malignancies, Adverse Events, Registries, Study Population, Human
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Research, Clinical Practice (Health Services and Quality), Elderly, Bispecific Antibody Therapy, Plasma Cell Disorders, Clinical Research, Health outcomes research, Supportive Care, Education, Health disparities research, Diseases, Therapy sequence, Immune Disorders, Immunodeficiency, Patient-reported outcomes, Treatment Considerations, Real-world evidence, Biological therapies, Lymphoid Malignancies, Adverse Events, Registries, Study Population, Human
Sunday, December 8, 2024: 4:30 PM-6:00 PM
San Diego Ballroom AB
(Marriott Marquis San Diego Marina)
Moderators:
Srinivas Devarakonda, MD, The Ohio State University Comprehensive Cancer Center
and
Nadine Abdallah, MD, Mayo Clinic
Disclosures:
No relevant conflicts of interest to declare.
Frailty and symptom assessment are critical but oft ignored part of the myeloma evaluation and treatment. These abstracts will review new frailty models, assessments and interventions.
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH